Register Login

PAVMED INC. (PAVM)

SymbolPAVM
NamePAVMED INC.
SectorHEALTH CARE
RegionNorth America
IndustryMedical/Dental Instruments
Address60 EAST 42ND STREET,SUITE 4600, NEW YORK, New York, 10165, United States
Telephone+1 212 949-4319
Fax—
Email—
Websitehttps://www.pavmed.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001624326
Description

PAVmed Inc is a medical device company engaged in advancing a pipeline of medical technologies from concept to commercialization using a business model focused on capital and time efficiency. Its product includes EsoCheck; CarpX; EsoGuard; PortIO; DisappEAR and others.

Additional info from NASDAQ:
PAVmed Inc is a medical device company engaged in advancing a pipeline of medical technologies from concept to commercialization using a business model focused on capital and time efficiency. Its product includes EsoCheck; CarpX; EsoGuard; PortIO; DisappEAR and others.

2026-05-15 18:48

New Form SCHEDULE 13G - PAVmed Inc. <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0001011438-26-000349 <b>Size:</b> 19 KB

Read more
2026-05-15 12:05

(75% Positive) PAVMED INC. (PAVM) Reports Q2 2026 Financial Results

Read more
2026-05-14 17:33

New Form SCHEDULE 13G - PAVmed Inc. <b>Filed:</b> 2026-05-14 <b>AccNo:</b> 0000728083-26-000004 <b>Size:</b> 9 KB

Read more
2026-05-11 18:58

New Form SCHEDULE 13G/A - PAVmed Inc. <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0001493152-26-022317 <b>Size:</b> 12 KB

Read more
2026-05-01 10:29

New Form DEF 14A - PAVmed Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001493152-26-020705 <b>Size:</b> 4 MB

Read more
2026-04-30 18:02

New Form DEFA14A - PAVmed Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001493152-26-020713 <b>Size:</b> 1 MB

Read more
2026-04-30 18:01

New Form ARS - PAVmed Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001493152-26-020710 <b>Size:</b> 2 MB

Read more
2026-04-30 07:14

New Form EFFECT - PAVmed Inc. <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 9999999995-26-001387 <b>Size:</b> 1 KB

Read more
2026-04-29 17:16

New Form 424B3 - PAVmed Inc. <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 0001493152-26-019594 <b>Size:</b> 342 KB

Read more
2026-04-23 12:30

Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock

Read more
Trial ID Title Phase Indication Status Start Date Completion Date Source
NCT06037265 PR-0164 First in Human Clinical Trial of the PAVmed PortIO Intraosseous Infusio… Na Chronic Kidney Disease stage3 Completed 2022-01-20 2024-07-29 ClinicalTrials.gov
NCT03747510 PAVmed CarpX Device Clinical Study Na Carpal Tunnel Syndrome Completed 2019-01-05 2019-12-30 ClinicalTrials.gov
Total clinical trials: 2
Product Name Type Development Stage Therapeutic Area Study Status Trial ID
CarpX Device Device Approved Carpal Tunnel Syndrome COMPLETED NCT03747510
PAVmed PortIO™ Intraosseous Infusion System Other Approved Chronic Kidney Disease stage3 COMPLETED NCT06037265
PAVmed PortIO™ Intraosseous Infusion System DEVICE Approved Chronic Kidney Disease stage3 COMPLETED NCT06037265
CarpX Device DEVICE Approved Carpal Tunnel Syndrome COMPLETED NCT03747510
Total products: 4